Mark J Tarr sold $17M of EHC
President & CEO at Encompass Health Corp. 150,000 shares at an average of $111.64, traded Feb 11, 2026, filed Feb 12, 2026.
Score components
- +25RoleCEO
- +25Trade size$16.7M at market
- +10Share of holdings soldSold 28% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -10.4%, 3m -4.1%, 6m +10.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000785161-26-000032, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 11, 2026 | SOpen-market sale Encompass Health Common Stock | -16,216 | $108.03 | $1.8M | 510,854 | Feb 12, 2026 |
| Feb 11, 2026 | SOpen-market sale Encompass Health Common Stock | -13,231 | $108.80 | $1.4M | 497,623 | Feb 12, 2026 |
| Feb 11, 2026 | SOpen-market sale Encompass Health Common Stock | -15,584 | $110.07 | $1.7M | 482,039 | Feb 12, 2026 |
| Feb 11, 2026 | SOpen-market sale Encompass Health Common Stock | -10,954 | $110.92 | $1.2M | 471,085 | Feb 12, 2026 |
| Feb 11, 2026 | SOpen-market sale Encompass Health Common Stock | -6,057 | $111.89 | $678k | 465,028 | Feb 12, 2026 |
| Feb 11, 2026 | SOpen-market sale Encompass Health Common Stock | -87,745 | $113.09 | $9.9M | 377,283 | Feb 12, 2026 |
| Feb 11, 2026 | SOpen-market sale Encompass Health Common Stock | -213 | $113.58 | $24k | 377,070 | Feb 12, 2026 |
Related signals
Other insiders at Encompass Health Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 27Weak | Encompass Health Corp | John Patrick Darby EVP, Gen Counsel & Secretary | $588k 4,858 shares | -6% | |
| 43Moderate | Encompass Health Corp | Andrew L Price Chief Accounting Officer | $630k 5,211 shares | -7% | |
| 72Notable | Encompass Health Corp | Douglas E Coltharp EVP & Chief Financial Officer | $2.4M 18,869 shares | -27% | |
| 60Notable | Encompass Health Corp | John Patrick Darby EVP, Gen Counsel & Secretary | $1.1M 8,906 shares | -11% | |
| 75Notable | Encompass Health Corp | Mark J Tarr President & CEO | $22M 173,148 shares | -39% | |
| 50Moderate | Encompass Health Corp | Douglas E Coltharp EVP & Chief Financial Officer | $3.0M 27,694 shares | -29% | |
| 36Weak | Encompass Health Corp | Patrick William Tuer EVP, Chief Operating Officer | $71k 682 shares | -3% | |
| 52Moderate | EHCsell Encompass Health Corp | Edmund Fay Sr. Vice Pres. and Treasurer | $1.3M 11,937 shares | -12% | |
| 47Moderate | Encompass Health Corp | Patrick William Tuer EVP, Chief Operating Officer | $302k 2,804 shares | -15% | |
| 31Weak | EHCsell Encompass Health Corp | Patrick William Tuer EVP, Chief Operating Officer | $126k 1,020 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.